EBRI
Rita Levi-Montalcini
Founded in 2002 by Nobel Laureate Rita Levi-Montalcini, EBRI is an international research center that fosters and promotes brain research with the aim of finding new therapies for neurodegenerative diseases and other neurological disorders.
Learn moreSupport EBRI
We rely on your help to advance brain research and accelerate the discovery of treatments for neuropsychiatric diseases.
Learn moreDesignate your “5x1000” to EBRI
A simple gesture can help us find a cure for brain diseases
Learn how you can be part of the next research discovery
Notte Europea dei Ricercatori 2022
Anche quest'anno la Fondazione EBRI Rita Levi-Montalcini è partner di Frascati Scienza per la Notte Europea dei Ricercatori.
Learn moreNon si ferma il viaggio della ricerca
Con CartaFRECCIA puoi sostenere le ricercatrici ucraine accolte nei laboratori dell'EBRI
Scopri di piùEBRI joins EBRAINS as an Associate Member
EBRAINS is a new research infrastructure, created by EU-funded Human Brain Project (HBP), which brings together a wide range of cutting-edge tools and services to be used to address the challenges of brain research.
Further Information
European Brain Research Institute
Rita Levi-Montalcini
The brain is a very complex, mysterious and fascinating organ and remains a frontier to be explored. The objectives of the European Brain Research Institute (EBRI), founded in 2002 by Nobel Laureate Rita Levi-Montalcini, are directed at better understanding brain function, so as to develop new treatments for brain diseases.
EBRI is a research institute recognized at the national and international level for its brain research and the development of new therapeutic approaches for neurological and psychiatric disorders. The Institute offers a collaborative and stimulating international scientific environment and is also actively engaged in disseminating and enhancing scientific knowledge.
Scientific research at EBRI
From basic research on molecular and cellular mechanisms of nerve cells, synapses and circuits, to the development of new diagnostic biomarkers and new therapeutic strategies for neurological and neurodegenerative diseases affecting the brain, such as Alzheimer's disease and senile dementia, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy, chronic pain, neurodevelopmental diseases of pediatric age. Our researchers employ a multidisciplinary approach, using state-of-the-art experimental and computational techniques.
Scientific collaborations
EBRI is part of an extensive network of collaborations with national and international research centers and hospitals, with the aim of creating synergies, expanding research lines and encouraging multidisciplinary scientific approaches.
Our Founder
Rita Levi-Montalcini dedicated her life to research, resolutely facing every obstacle, from racial discrimination to an archaic conception of the role of women in society and science. At the age of 93, she founded EBRI, an international research institute dedicated entirely to the study of the brain.
